$6.46
0.223.53%
At Close: -
$6.50
0.040.62%
After Hours: 7:46 AM EDT
15 minutes delayed
Comments
Loading...
Telomir Pharmaceuticals (TELO) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestTelomir Pharmaceuticals (NASDAQ:TELO) Stock Quotes, Forecast and News Summary
Telomir Pharmaceuticals Stock (NASDAQ: TELO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Telomir Pharmaceuticals (TELO) stock?
You can purchase shares of Telomir Pharmaceuticals (NASDAQ:TELO) through any online brokerage.
Who are Telomir Pharmaceuticals (TELO) competitors?
Other companies in Telomir Pharmaceuticals’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), GH Research (NASDAQ:GHRS), Marinus Pharma (NASDAQ:MRNS), Esperion Therapeutics (NASDAQ:ESPR) and Trevi Therapeutics (NASDAQ:TRVI).
What is the forecast, or price target, for Telomir Pharmaceuticals (TELO) stock?
There is no analysis for Telomir Pharmaceuticals to provide a consensus price target.
What is the current price for Telomir Pharmaceuticals (TELO)?
The stock price for Telomir Pharmaceuticals (NASDAQ: TELO) is $6.5 last updated September 26, 2024 at 7:46 AM EDT.
Does Telomir Pharmaceuticals (TELO) pay a dividend?
There are no upcoming dividends for Telomir Pharmaceuticals.
When is Telomir Pharmaceuticals (NASDAQ:TELO) reporting earnings?
Telomir Pharmaceuticals’s Q2 earnings are confirmed for Tuesday, August 13, 2024.
Is Telomir Pharmaceuticals (TELO) going to split?
There is no upcoming split for Telomir Pharmaceuticals.
What sector and industry does Telomir Pharmaceuticals (TELO) operate in?
Telomir Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.